Loading…
Osteonecrosis of the jaw related to everolimus and bisphosphonate: a unique case report?
Osteonecrosis of the jaw (ONJ) is a rare but serious lesion of the jaw, characterized mainly by exposed necrotic bone; it is related to various drugs, usually used for treating patients with advanced malignancies. Drugs implicated in ONJ are: nitrogen-containing bisphosphonates (NBP), denosumab, ant...
Saved in:
Published in: | Annali di stomatologia 2013, Vol.4 (Suppl 2), p.20-21 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Osteonecrosis of the jaw (ONJ) is a rare but serious lesion of the jaw, characterized mainly by exposed necrotic bone; it is related to various drugs, usually used for treating patients with advanced malignancies. Drugs implicated in ONJ are: nitrogen-containing bisphosphonates (NBP), denosumab, anti-angiogenic drugs and the selective mammalian target of rapamycin mTOR, everolimus. Previous data regarding the combining of NBPs with antiangiogenic agents conflict with some reports; other reports show significantly higher rates of the incidence of ONJ^sup 2^. |
---|---|
ISSN: | 1824-0852 1971-1441 |